Identify sequence candidates from biopanning

A key question in therapeutic antibody drug discovery is how to identify the most promising sequence candidates from a biopanning experiment using next-generation sequencing (NGS) data. This can easily be done using built-in tools in the PipeBio platform, without prior bioinformatics or coding experience. In this post, we’ll re-analyze the NGS data published in Hanke… Continue reading Identify sequence candidates from biopanning

Published
Categorized as PipeBio

Data Driven Decision Making in Biologics Drug Discovery

In biologics drug discovery, a biomolecule from its origins to the candidate drug status undergoes a variety of characterizations. Such characterizations are aimed to define the effectiveness, specificity, potency, adverse effects, pharmacology, and in vivo efficacy of the candidate biomolecules. Decades of advancements in biophysical methods that can analyze drug interactions with a particular target… Continue reading Data Driven Decision Making in Biologics Drug Discovery

Published
Categorized as PipeBio